drugset / Trial / NCT04085653

Managed Access Programs for BYL719, Alpelisib

NCT04085653

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to BYL719, Alpelisib

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Alpelisib Small molecule